Core Insights - LifeMD, Inc. reported strong financial results for Q2 2025, with total revenue increasing by 23% year-over-year to $62.2 million, driven by a 30% increase in telehealth revenue [2][8][9] - The company is expanding its telehealth platform into high-need clinical areas, including a nationwide behavioral health offering and a virtual women's health brand acquisition [4][5] - LifeMD's adjusted EBITDA rose significantly by 223% to $7.1 million, with telehealth adjusted EBITDA increasing by 560% to $3.4 million [5][8][9] Financial Performance - Total revenue for Q2 2025 was $62.2 million, up from $50.7 million in Q2 2024, with telehealth revenue reaching $48.6 million [8][9] - The number of active telehealth subscribers grew by 16% to approximately 297,000 [9][10] - The company generated over $8 million in operating cash flow and exited the quarter with $36.2 million in cash after fully repaying all senior debt [5][9] Operational Highlights - LifeMD launched a nationwide behavioral health offering and acquired a women's health brand to enhance its service offerings [4][5] - The enhanced LifeMD+ membership program was scaled to provide 24/7 urgent and primary care, along with specialty care and wellness products [4][5] - The company reported a gross margin of 88%, slightly down from 90% in the prior year due to revenue mix [9] Guidance and Outlook - LifeMD revised its full-year 2025 guidance for total revenue to a range of $250 million to $255 million, down from previous guidance of $268 million to $275 million [14] - The company expects telehealth revenue for the full year to be in the range of $195 million to $200 million, compared to earlier estimates of $208 million to $213 million [14] - Adjusted EBITDA guidance for the full year was also revised down to a range of $27 million to $29 million from $31 million to $33 million [14]